Pexidartinib T2115
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
CAS nr:
1029044-16-3
Purity:
98%
Molecular Weight:
417,81
SMILES:
FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1
Formula:
C20H15ClF3N5
Pathway:
Tyrosine Kinase/Adaptors,Apoptosis,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors
Target:
CSF-1R,Apoptosis,c-Fms,FLT,FLT,c-Kit
